Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 68657

1.

Diabetes Intervention Accentuating Diet and Enhancing Metabolism (DIADEM-I): a randomised controlled trial to examine the impact of an intensive lifestyle intervention consisting of a low-energy diet and physical activity on body weight and metabolism in early type 2 diabetes mellitus: study protocol for a randomized controlled trial.

Taheri S, Chagoury O, Zaghloul H, Elhadad S, Ahmed SH, Omar O, Payra S, Ahmed S, El Khatib N, Amona RA, El Nahas K, Bolton M, Chaar H, Suleiman N, Jayyousi A, Zirie M, Janahi I, Elhag W, Alnaama A, Zainel A, Hassan D, Cable T, Charlson M, Wells M, Al-Hamaq A, Al-Abdulla S, Abou-Samra AB.

Trials. 2018 May 21;19(1):284. doi: 10.1186/s13063-018-2660-1.

PMID:
29784059
2.

Combined Administration of Monosodium Glutamate and High Sucrose Diet Accelerates the Induction of Type 2 Diabetes, Vascular Dysfunction, and Memory Impairment in Rats.

Saikrishna K, Kumari R, Chaitanya K, Biswas S, Nayak PG, Mudgal J, Kishore A, Nandakumar K.

J Environ Pathol Toxicol Oncol. 2018;37(1):63-80. doi: 10.1615/JEnvironPatholToxicolOncol.2018017186.

PMID:
29773001
3.

Feasibility and effectiveness of electrochemical dermal conductance measurement for the screening of diabetic neuropathy in primary care. DECODING Study (Dermal Electrochemical Conductance in Diabetic Neuropathy). Rationale and design.

Cabré JJ, Mur T, Costa B, Barrio F, López-Moya C, Sagarra R, García-Barco M, Vizcaíno J, Bonaventura I, Ortiz N, Flores-Mateo G; Catalan Diabetes Prevention Research Group.

Medicine (Baltimore). 2018 May;97(20):e10750. doi: 10.1097/MD.0000000000010750.

4.

MANAGEMENT OF ENDOCRINE DISEASE: Which metabolic procedure? Comparing outcomes in Sleeve Gastrectomy and Roux-en Y Gastric Bypass.

Billeter AT, de la Garza Herrera J, Scheurlen KM, Nickel F, Billmann F, Müller-Stich B.

Eur J Endocrinol. 2018 May 15. pii: EJE-18-0009. doi: 10.1530/EJE-18-0009. [Epub ahead of print]

PMID:
29764908
5.

Health and quality of life outcomes impairment of quality of life in type 2 diabetes mellitus: a cross-sectional study.

Zurita-Cruz JN, Manuel-Apolinar L, Arellano-Flores ML, Gutierrez-Gonzalez A, Najera-Ahumada AG, Cisneros-González N.

Health Qual Life Outcomes. 2018 May 15;16(1):94. doi: 10.1186/s12955-018-0906-y.

6.

Schizophrenia and type 2 diabetes mellitus.

Mamakou V, Thanopoulou A, Gonidakis F, Tentolouris N, Kontaxakis V.

Psychiatriki. 2018 Jan-Mar;29(1):64-73. doi: 10.22365/jpsych.2018.291.64.

PMID:
29754122
7.

Flavonoids intake and risk of type 2 diabetes mellitus: A meta-analysis of prospective cohort studies.

Xu H, Luo J, Huang J, Wen Q.

Medicine (Baltimore). 2018 May;97(19):e0686. doi: 10.1097/MD.0000000000010686.

8.

Effectiveness of Internet-Based Interventions on Glycemic Control in Patients With Type 2 Diabetes: Meta-Analysis of Randomized Controlled Trials.

Shen Y, Wang F, Zhang X, Zhu X, Sun Q, Fisher E, Sun X.

J Med Internet Res. 2018 May 7;20(5):e172. doi: 10.2196/jmir.9133.

9.

NEW ALTERNATIVE TREATMENTS.

Stevelos J.

Diabetes Self Manag. 2017 May;34(3):34-36. No abstract available.

PMID:
29714850
10.

Sustaining quality in the community: trends in the performance of a structured diabetes care programme in primary care over 16 years.

Riordan F, McHugh SM, Harkins V, Marsden P, Kearney PM.

Diabet Med. 2018 Apr 29. doi: 10.1111/dme.13658. [Epub ahead of print]

PMID:
29706032
11.

Cardiovascular Disease in Japanese Patients with Type 2 Diabetes Mellitus.

Fujihara K, Sone H.

Ann Vasc Dis. 2018 Mar 25;11(1):2-14. doi: 10.3400/avd.ra.17-00109. Review.

12.
13.
14.

Costs and effectiveness of pharmacist-led group medical visits for type-2 diabetes: A multi-center randomized controlled trial.

Wu WC, Taveira TH, Jeffery S, Jiang L, Tokuda L, Musial J, Cohen LB, Uhrle F.

PLoS One. 2018 Apr 19;13(4):e0195898. doi: 10.1371/journal.pone.0195898. eCollection 2018.

15.

The effect of fenofibrate on early retinal nerve fiber layer loss in type 2 diabetic patients: a case-control study.

Shi R, Zhao L, Qi Y.

BMC Ophthalmol. 2018 Apr 18;18(1):100. doi: 10.1186/s12886-018-0769-3.

16.

The impact of a disease management programme for type 2 diabetes on health-related quality of life: multilevel analysis of a cluster-randomised controlled trial.

Panisch S, Johansson T, Flamm M, Winkler H, Weitgasser R, Sönnichsen AC.

Diabetol Metab Syndr. 2018 Apr 10;10:28. doi: 10.1186/s13098-018-0330-9. eCollection 2018.

17.

Effects of linagliptin versus voglibose on treatment-related quality of life in patients with type 2 diabetes: sub-analysis of the L-STEP study.

Goto H, Mita T, Fujitani Y, Fujimoto S, Takahashi K, Satoh H, Hirose T, Hiyoshi T, Ai M, Okada Y, Nishimura H, Kuroda H, Matsubara T, Gosho M, Ishii H, Watada H.

Endocr J. 2018 Apr 10. doi: 10.1507/endocrj.EJ18-0088. [Epub ahead of print]

18.

SCREENING FOR TYPE 2 DIABETES MELLITUS AND PREDIABETES USING POINT-OF-CARE TESTING FOR HBA1C AMONG THAI DENTAL PATIENTS.

Tantipoj C, Sakoolnamarka SS, Supa-amornkul S, Lohsoonthorn V, Deerochanawong C, Khovidhunkit SP, Hiransuthikul N.

Southeast Asian J Trop Med Public Health. 2017 Mar;48(2):455-65.

PMID:
29642309
19.

VEGF levels in plasma in relation to metabolic control, inflammation, and microvascular complications in type-2 diabetes: A cohort study.

Zhang Q, Fang W, Ma L, Wang ZD, Yang YM, Lu YQ.

Medicine (Baltimore). 2018 Apr;97(15):e0415. doi: 10.1097/MD.0000000000010415.

20.

Circulating LECT2 levels in newly diagnosed type 2 diabetes mellitus and their association with metabolic parameters: An observational study.

Zhang Z, Zeng H, Lin J, Hu Y, Yang R, Sun J, Chen R, Chen H.

Medicine (Baltimore). 2018 Apr;97(15):e0354. doi: 10.1097/MD.0000000000010354.

Supplemental Content

Loading ...
Support Center